Mednet Logo
CommunityNeurology

How will you counsel patients regarding ARIA?

Do you see utility in trending serum neurofilament light chain levels or any alternative screening methods beyond MRI to help identify amyloid-related imaging abnormalities earlier? How will you approach patients considering these treatments who cannot get MRIs?
Community PollStarted

What do you anticipate will be the biggest system barriers to proper adoption and use of anti-amyloid therapies?

30 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet Member
Mednet MemberInvited Expert
Neurology · Baylor College of Medicine
Answered on

It is possible that with real-life experience and further study, blood biomarkers will be validated as early detection signs of ARIA, but right now we are left with MRI. I believe that we need a lot more real-world data about these drugs before we consider alternative ways to diagnose and screen for...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Neurology · Stanford University
Answered on

How will you counsel patients regarding ARIA?

  • I will convey the following: "ARIA is a side effect that does not usually cause any symptoms but serious symptoms can occur. ARIA is most commonly seen as temporary swelling in areas of the brain that usually resolves over time. Some people may also hav...

Join for free or sign in to see the full answer